APA (7th ed.) Citation

Oderda, M., Orlando, G., Calleris, G., Capella, G., Delsedime, L., Duregon, E., . . . Gontero, P. (2025). Role of Cell‐Cycle Proliferation Test, Triple Hit Phenotype, and TMPRSS2‐ERG Expression to Evaluate the Risk of Progression in Prostate Cancer Patients Under Active Surveillance. Wiley. https://doi.org/10.1002/pros.24921

Chicago Style (17th ed.) Citation

Oderda, Marco, et al. Role of Cell‐Cycle Proliferation Test, Triple Hit Phenotype, and TMPRSS2‐ERG Expression to Evaluate the Risk of Progression in Prostate Cancer Patients Under Active Surveillance. Wiley, 2025. https://doi.org/10.1002/pros.24921.

MLA (9th ed.) Citation

Oderda, Marco, et al. Role of Cell‐Cycle Proliferation Test, Triple Hit Phenotype, and TMPRSS2‐ERG Expression to Evaluate the Risk of Progression in Prostate Cancer Patients Under Active Surveillance. Wiley, 2025. https://doi.org/10.1002/pros.24921.